INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 38 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $48,000 | -66.2% | 65,649 | +101.3% | 0.00% | -69.2% |
| Q2 2019 | $142,000 | -69.6% | 32,609 | -48.8% | 0.01% | -71.1% |
| Q1 2019 | $467,000 | -15.9% | 63,692 | -13.5% | 0.04% | -44.4% |
| Q4 2018 | $555,000 | +228.4% | 73,669 | +146.3% | 0.08% | +376.5% |
| Q3 2018 | $169,000 | +53.6% | 29,905 | +19.7% | 0.02% | +70.0% |
| Q2 2018 | $110,000 | – | 24,982 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 650,000 | $2,989,000 | 2.00% |
| Cormorant Asset Management, LP | 809,804 | $3,724,000 | 0.53% |
| DAFNA Capital Management LLC | 119,296 | $549,000 | 0.44% |
| SABBY MANAGEMENT, LLC | 743,545 | $3,346,000 | 0.18% |
| Migdal Insurance & Financial Holdings Ltd. | 495,000 | $2,277,000 | 0.06% |
| UBS Group AG | 2,346 | $11,000 | 0.00% |